Sommaire

• • ·Table of Contents

    Page :A5

    
• • ·Editorial Board

    Page :A10

    
• • ·Information for Authors

    Page :A11

    
• • ·Information for Authors

    Page :A12

    
• • ·Information for Readers

    Page :A13

    
• • ·Author Index

    Page :1095-1112

    
• • ·Subject Index

    Page :1113-1132

    

• Editorial

  • ·The value of approved therapies for pulmonary arterial hypertension

    Page :889-890

    Stuart Rich

    

• Curriculum in Cardiology

  • ·Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

    Page :891-899

    Akshay Gupta, Andrew T. Lawrence, Kousik Krishnan, Clifford J. Kavinsky, Richard G. Trohman

    Résumé Résumé Plan Plan  
  • ·Beyond the platelet count: Heparin antibodies as independent risk predictors

    Page :900-906

    W. Kyle Stribling, Thomas F. Slaughter, Timothy T. Houle, David C. Sane

    Résumé Résumé Plan Plan  
  • ·Human epicardial adipose tissue: A review

    Page :907-917

    Harold S. Sacks, John N. Fain

    Résumé Résumé Plan Plan  

• Trial Design

  • ·Hypertension Intervention Nurse Telemedicine Study (HINTS): Testing a multifactorial tailored behavioral/educational and a medication management intervention for blood pressure control

    Page :918-924

    Hayden B. Bosworth, Maren K. Olsen, Felicia McCant, Mikeal Harrelson, Pamela Gentry, Cynthia Rose, Mary K. Goldstein, Brian B. Hoffman, Benjamin Powers, Eugene Z. Oddone

    Résumé Résumé Plan Plan  
  • ·Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis : The Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) trial

    Page :925-931

    Kwan-Leung Chan, Koon Teo, James Tam, Jean G. Dumesnil, for the Astronomer Investigators

    Résumé Résumé Plan Plan
  • ·Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: A multicenter clinical outcomes trial using nesiritide for TMAC

    Page :932-940

    Mandeep R. Mehra, Ted McCluskey, Mark Barr, Robert C. Bourge, Mariell L. Jessup, Donna Mancini, Branislav Radovancevic, Barry Rayburn, David O. Taylor, Jane Lilly-Hersley, Peter Linde

    Résumé Résumé Plan Plan  

• Results of Expert Meetings

  • ·Preventing tomorrow's sudden cardiac death today : Part I: Current data on risk stratification for sudden cardiac death

    Page :941-950

    Sana M. Al-Khatib, Gillian D. Sanders, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne Curtis, Jeptha Curtis, Eric Fain, Bernard J. Gersh, Michael R. Gold, Ali Haghighi-Mood, Stephen C. Hammill, Jeff Healey, Mark Hlatky, Stefan Hohnloser, Raymond J. Kim, Kerry Lee, Daniel Mark, Marcus Mianulli, Brent Mitchell, Eric N. Prystowsky, Joseph Smith, David Steinhaus, Wojciech Zareba, for an expert panel participating in a Duke's Center for the Prevention of Sudden Cardiac Death conference

    Résumé Résumé Plan Plan
  • ·Preventing tomorrow's sudden cardiac death today : Part II: Translating sudden cardiac death risk assessment strategies into practice and policy

    Page :951-959

    Gillian D. Sanders, Sana M. Al-Khatib, Elise Berliner, J. Thomas Bigger, Alfred E. Buxton, Robert M. Califf, Mark Carlson, Anne B. Curtis, Jeptha P. Curtis, Michael Domanski, Eric Fain, Bernard J. Gersh, Michael R. Gold, Jeffrey Goldberger, Ali Haghighi-Mood, Stephen C. Hammill, Joel Harder, Jeffrey Healey, Mark A. Hlatky, Stefan H. Hohnloser, Kerry L. Lee, Daniel B. Mark, Brent Mitchell, Steve Phurrough, Eric Prystowsky, Joseph M. Smith, Norman Stockbridge, Robert Temple, for an expert panel participating in a Duke Center for the Prevention of Sudden Cardiac Death-sponsored conference

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

    Page :960-969

    David Brieger, Frans Van de Werf, Álvaro Avezum, Gilles Montalescot, Brian M. Kennelly, Christopher B. Granger, Shaun G. Goodman, Omar H. Dabbous, Giancarlo Agnelli, for the GRACE Investigators

    Résumé Résumé Plan Plan  
  • ·Sex-specific effects of diabetes on adverse outcomes after percutaneous coronary intervention: Trends over time

    Page :970-978

    Kimberly P. Champney, Emir Veledar, Mitchel Klein, Habib Samady, Deborah Anderson, Susmita Parashar, Nanette Wenger, Viola Vaccarino

    Résumé Résumé Plan Plan  
  • ·Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: Serial angiographic and sonographic analysis

    Page :979.e1

    Andreas König, Markus Leibig, Johannes Rieber, Thomas Michael Schiele, Karl Theisen, Uwe Siebert, Raffaella Matteucci Gothe, Volker Klauss

    Résumé Résumé Plan Plan  
  • ·Secondary prevention outcomes among black and white cardiac rehabilitation patients

    Page :980-986

    Bonnie K. Sanderson, Saema Mirza, Rachel Fry, Jeroan J. Allison, Vera Bittner

    Résumé Résumé Plan Plan  
  • ·Elevated vascular endothelial growth factor levels are associated with aortopulmonary collateral vessels in patients before and after the Fontan procedure

    Page :987-994

    Yoshiki Mori, Makiko Shoji, Toshio Nakanishi, Takanari Fujii, Makoto Nakazawa

    Résumé Résumé Plan Plan  
  • ·Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: Comparison of early with recent results in small children

    Page :995-1000

    Etsuko Tsuda, Soichiro Kitamura, Kohji Kimura, Junjiro Kobayashi, Shunichi Miyazaki, Shigeyuki Echigo, Toshikatsu Yagihara

    Résumé Résumé Plan Plan  
  • ·Association between cardiorespiratory fitness and prevalence of carotid atherosclerosis among men with hypertension

    Page :1001-1005

    Sae Young Jae, Mercedes R. Carnethon, Kevin S. Heffernan, Yoon-Ho Choi, Moon-Kyu Lee, Bo Fernhall

    Résumé Résumé Plan Plan  
  • ·Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation

    Page :1006-1012

    Robby Nieuwlaat, S. Bertil Olsson, Gregory Y.H. Lip, A. John Camm, Günter Breithardt, Alessandro Capucci, Joan G. Meeder, Martin H. Prins, Samuel Lévy, Harry J.G.M. Crijns, on behalf of the Euro Heart Survey Investigators

    Résumé Résumé Plan Plan  
  • ·Prognostic role of transesophageal echocardiography in acute type A aortic dissection

    Page :1013-1020

    Eduardo Bossone, Arturo Evangelista, Eric Isselbacher, Santi Trimarchi, Stuart Hutchison, Dan Gilon, Alfredo Llovet, Patrick O'Gara, Jeanna V. Cooper, Jianming Fang, James L. Januzzi, Rajendra H. Mehta, Alessandro Distante, Christoph A. Nienaber, Kim Eagle, William F. Armstrong, on behalf of the International Registry of Acute Aortic Dissection (IRAD) Investigators

    Résumé Résumé Plan Plan
  • ·Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE)

    Page :1021-1028

    Gregg C. Fonarow, J. Thomas Heywood, Paul A. Heidenreich, Margarita Lopatin, Clyde W. Yancy, for the ADHERE Scientific Advisory Committee and Investigators

    Résumé Résumé Plan Plan  
  • ·?-Blocker dosing in community-based treatment of heart failure

    Page :1029-1036

    Michael B. Fowler, Sandra R. Lottes, Jeanenne J. Nelson, Mary Ann Lukas, Edward M. Gilbert, Barry Greenberg, Barry M. Massie, William T. Abraham, Joseph A. Franciosa, for the COHERE Participant Physicians

    Résumé Résumé Plan Plan  
  • ·A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology

    Page :1037-1047

    Alejandro Macchia, Roberto Marchioli, RosaMaria Marfisi, Marco Scarano, Giacomo Levantesi, Luigi Tavazzi, Gianni Tognoni

    Résumé Résumé Plan Plan  
  • ·Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure

    Page :1048-1055

    Jonathan D. Windram, Puan H. Loh, Alan S. Rigby, Ian Hanning, Andrew L. Clark, John G.F. Cleland

    Résumé Résumé Plan Plan  
  • ·Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: A prospective randomized controlled study

    Page :1055.e1

    Takahisa Yamada, Koichi Node, Takanao Mine, Takashi Morita, Hidetaka Kioka, Yasumasa Tsukamoto, Shunsuke Tamaki, Masaharu Masuda, Keiji Okuda, Masatake Fukunami

    Résumé Résumé Plan Plan  
  • ·Effects of exercise training on heart rate recovery in patients with chronic heart failure

    Page :1056-1063

    Jonathan Myers, David Hadley, Ulrike Oswald, Karin Bruner, Wilhard Kottman, Leon Hsu, Paul Dubach

    Résumé Résumé Plan Plan  
  • ·Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease

    Page :1064-1073

    Alan K. Berger, Sue Duval, Connie Manske, Gabriela Vazquez, Cheryl Barber, Leslie Miller, Russell V. Luepker

    Résumé Résumé Plan Plan  
  • ·Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction

    Page :1074-1080

    François Alla, Ahmad Y. Al-Hindi, Craig R. Lee, Todd A. Schwartz, J. Herbert Patterson, Kirkwood F. Adams

    Résumé Résumé Plan Plan  
  • ·Relation of early improvement in coronary flow reserve to late recovery of left ventricular function after ?-blocker therapy in patients with idiopathic dilated cardiomyopathy

    Page :1080.e1

    Kenichi Sugioka, Takeshi Hozumi, Yasuhiko Takemoto, Shoichi Ehara, Keitaro Ogawa, Shinchi Iwata, Hiroki Oe, Yoshiki Matsumura, Ryo Otsuka, Minoru Yoshiyama, Junichi Yoshikawa

    Résumé Résumé Plan Plan  
  • ·Coronary endothelial dysfunction and hyperlipidemia are independently associated with diastolic dysfunction in humans

    Page :1081-1087

    Ahmad A. Elesber, Margaret M. Redfield, Charanjit S. Rihal, Abhiram Prasad, Shahar Lavi, Ryan Lennon, Verghese Mathew, Lilach O. Lerman, Amir Lerman

    Résumé Résumé Plan Plan  
  • ·Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost

    Page :1088.e1

    Birger Wolff, Sven Lodziewski, Tom Bollmann, Christian F. Opitz, Ralf Ewert

    Résumé Résumé Plan Plan  
  • ·Where patients with mild to moderate heart failure die: Results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

    Page :1089-1094

    Brian Olshansky, Freda Wood, Anne S. Hellkamp, Jeanne E. Poole, Jill Anderson, George W. Johnson, Robin Boineau, Michael J. Domanski, Daniel B. Mark, Kerry L. Lee, Gust H. Bardy, for the SCD-HeFT Investigators

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Letter to the Editor

    Page :e33

    Frans van de Werf

    
  • ·Response to the letter to the Editor by van de Werf

    Page :e35

    Su San Liem, J. Wouter Jukema, Martin J. Schalij

    
  • ·?-Blockers do not always reduce perioperative events: check catecholamines levels postoperatively: Letter to the Editor

    Page :e37

    Luiz F. Souza, Ana C. Pereira, Paulo S. Lavinas

    
  • ·Failure of ?-blockers in the reduction of perioperative events: Where did we go wrong? : Response to the letter to the Editor by Souza et al

    Page :e39

    Peter A. McCullough

    
  • ·Letter to the Editor

    Page :e41

    Kür?at Kaptan, Ahmet Ifran, Cengiz Beyan

    
  • ·Mortality associated with nesiritide: Letter to the Editor

    Page :e43

    Richard J. Carroll, Zuber D. Mulla, Loran D. Hauck, Audrey Westbrook

    
  • ·Response

    Page :e45

    Rohit Arora, Prasanna K. Venkatesh, Janos Molnar